European Association of Urology Research Foundation
15
1
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
13.3%
2 terminated/withdrawn out of 15 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
2 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life
Role: lead
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
Role: collaborator
Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence
Role: lead
Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction
Role: lead
Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD
Role: lead
Sustainability in Urologic Practices
Role: collaborator
Prostate Cancer Awareness and Initiative for Screening in the European Union
Role: lead
ManAgement of pRiapiSm and Its Impact on Outcomes
Role: collaborator
Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery
Role: lead
European Registry of Next Generation Imaging in Advanced Prostate Cancer
Role: collaborator
Optilume Registry for Treatment of Stricture of the Anterior Urethra
Role: lead
Focal Therapy in Localized Prostate Cancer: a Prospective Registry
Role: collaborator
The Global Prevalence of Infections in Urology Study
Role: lead
Epidemiology and Outcomes of Gram Negative Urosepsis
Role: lead
Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Role: lead
All 15 trials loaded